Chemical and Pharmaceutical Bulletin
The Pharmaceutical Society of Japan, established in 1880, is one of Japan’s oldest and most distinguished academic societies. The Society currently has around 18,000 members. It publishes three monthly scientific journals. Chemical and Pharmaceutical Bulletin (Chem. Pharm. Bull.) began publication in 1953 as Pharmaceutical Bulletin. It covers chemistry fields in the pharmaceutical and health sciences. Biological and Pharmaceutical Bulletin (Biol. Pharm. Bull.) began publication in 1978 as the Journal of Pharmacobio-Dynamics. It covers various biological topics in the pharmaceutical and health sciences. A fourth Society journal, the Journal of Health Science, was merged with Biol. Pharm. Bull. in 2012. Yakugaku Zasshi (Japanese for “Pharmaceutical Science Journal”) has the longest history, with publication beginning in 1881. Yakugaku Zasshi is published mostly in Japanese, except for some articles related to clinical pharmacy and pharmaceutical education, which are published in English.
The main aim of the Society’s journals is to advance the pharmaceutical sciences with research reports, information exchange, and high-quality discussion. The average review time for articles submitted to the journals is around one month for first decision. The complete texts of all of the Society’s journals can be freely accessed through J-STAGE. The Society’s editorial committee hopes that the content of its journals will be useful to your research, and also invites you to submit your own work to the journals.

Chairman of Committee
Ken-ichi Hosoya
Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama

Read more
27,350 registered articles
(updated on April 23, 2019)
Online ISSN : 1347-5223
Print ISSN : 0009-2363
ISSN-L : 0009-2363
Featured article
Volume 67 (2019) Issue 4 Pages 367-371
A Simple and Easy Method of Monitoring Doxorubicin Release from a Liposomal Drug Formulation in the Serum Using Fluorescence Spectroscopy Read more
Editor’s picks

In order to maximize the effect of drugs, nanomedicines, drug-containing nanoparticles, have become popular in the field of medicine as they allow selective delivery of drugs to the disease target. It is important to understand the drug release form nanomedicine at the disease target. In this study, the authors developed a simple and easy method of monitoring drug release from nanomedicine using a fluorescence analysis, especially fluorescence fingerprint. The authors used DOXIL as a typical nanomedicine and found out that the release of the encapsulated drug, doxorubicin, is accelerated by albumin which is the most abundant protein in the blood.

Volume 67 (2019) Issue 4 Pages 289-298
Cyclodextrin-Based Molecular Accessories for Drug Discovery and Drug Delivery Read more
Editor’s picks

A person may choose to wear an accessory so as to enhance their appearance and give them confidence and thus a change of character. So what happens when accessories are decorated with drugs? The author has developed molecular accessories for drugs through supramolecular chemistry to create new medicines and pharmaceutical technologies. In this article, the author introduces cyclodextrin-based supramolecular accessories such as molecular necklace, molecular earring, and intelligent molecular necklace, and describes their application in pharmaceutical sciences. Moreover, the author proposes a new concept in pharmaceutical sciences termed as “supramolecular pharmaceutical sciences,” which combines pharmaceutical sciences and supramolecular chemistry.

View the past featured articles
Most viewed articles Mar.2019
Share this page
Select past volume & issue
Journal news & Announcements
  • Chem. Pharm. Bull. Vol. 67 No. 4
    Current Topics: Recent Progress in Biophysical Research of Biological Membrane Systems

  • Chem. Pharm. Bull. Vol. 67 No. 3
    Current Topics: Drug Discovery: Recent Progress and the Future